Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia.

Cardiolipin Central nervous system Damage-associated molecular patterns Microglia activation Mitochondrial DNA Multiple sclerosis N-formyl peptides Neurodegenerative diseases Reactive oxygen species

Journal

Molecular and cellular neurosciences
ISSN: 1095-9327
Titre abrégé: Mol Cell Neurosci
Pays: United States
ID NLM: 9100095

Informations de publication

Date de publication:
10 2020
Historique:
received: 05 12 2019
revised: 31 07 2020
accepted: 12 08 2020
pubmed: 24 8 2020
medline: 29 7 2021
entrez: 24 8 2020
Statut: ppublish

Résumé

Microglia are the resident innate immune cells of the central nervous system and exert functions of host defense and maintenance of normal tissue homeostasis, along with support of neuronal processes in the healthy brain. Chronic and dysregulated microglial cell activation has increasingly been linked to the status of neuroinflammation underlying many neurodegenerative diseases, including multiple sclerosis (MS). However, the stimulus (or stimuli) and mechanisms by which microglial activation is initiated and maintained MS are still debated. The purpose of our research was to investigate whether the endogenous mitochondrial (mt)-derived damage-associated molecular patterns (MTDs) mtDNA, N-formyl peptides and cardiolipin (CL) contribute to these phenomena. We characterized the effects of the abovementioned MTDs on microglia activation in vitro (i.e. using HMC3 cells) by evaluating the expression of gene coding for proteins involved in their binding and coupled to downstream signaling pathways, the up-regulation of markers of activation on the cell surface and the production of pro-inflammatory cytokines and reactive oxygen species. At the transcriptional level, significant variations in the mRNA relative expression of five of eleven selected genes were observed in response to stimulation. No changes in activation of antigenic profile or functional properties of HMC3 cells were observed; there was no up-regulation of HLA-DR expression or increased secretion of tumor necrosis factor-α and interleukin-6. However, after stimulation with mtDNA and CL, an increase in cellular oxidative stress, but not in the mt ROS O

Identifiants

pubmed: 32828963
pii: S1044-7431(20)30161-5
doi: 10.1016/j.mcn.2020.103538
pii:
doi:

Substances chimiques

Cardiolipins 0
HLA-DR Antigens 0
Interleukin-6 0
Lipopolysaccharides 0
Reactive Oxygen Species 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103538

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interest to declare.

Auteurs

Milena Nasi (M)

Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy. Electronic address: milena.nasi@unimore.it.

Anna De Gaetano (A)

Department of Life Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Elena Bianchini (E)

Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Sara De Biasi (S)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Lara Gibellini (L)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Anita Neroni (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Marco Mattioli (M)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Marcello Pinti (M)

Department of Life Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Domenico Lo Tartaro (D)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Rebecca Borella (R)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Anna Vittoria Mattioli (AV)

Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy; National Institute of Cardiovascular Research, via Irnerio, 48, 40126 Bologna, Italy.

Johanna Chester (J)

Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Alessandra Melegari (A)

Department of Laboratory Medicine and Pathology, Azienda Ospedaliero-Universitaria di Modena Ospedale Civile di Baggiovara, via Giardini, 1355, 41126 Baggiovara, MO, Italy.

Anna Maria Simone (AM)

Neurology Unit, Carpi Hospital, AUSL Modena, via Molinari, 2, 41012 Carpi, MO, Italy.

Diana Ferraro (D)

Department of Neurosciences, Azienda Ospedaliero-Universitaria di Modena Ospedale Civile di Baggiovara, via Giardini, 1355, 41126 Baggiovara, MO, Italy; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.

Francesca Vitetta (F)

Department of Neurosciences, Azienda Ospedaliero-Universitaria di Modena Ospedale Civile di Baggiovara, via Giardini, 1355, 41126 Baggiovara, MO, Italy.

Patrizia Sola (P)

Department of Neurosciences, Azienda Ospedaliero-Universitaria di Modena Ospedale Civile di Baggiovara, via Giardini, 1355, 41126 Baggiovara, MO, Italy.

Andrea Cossarizza (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy; National Institute of Cardiovascular Research, via Irnerio, 48, 40126 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH